Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
Tianjin Anding Hospital
🇨🇳
China
Country
🇨🇳
China
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Berberine Effects on Clinical Symptoms and Metabolic Disturbance in Patients With Schizophrenia
Not Applicable
Completed
Conditions
Schizophrenia
Therapeutics
Interventions
Drug: Berberine
Drug: atypical antipsychotic
Drug: placebo
Subscribe
First Posted Date
2018-06-07
Last Posted Date
2023-07-25
Lead Sponsor
Tianjin Anding Hospital
Target Recruit Count
65
Registration Number
NCT03548155
Subscribe
Berberine Treat Metabolic Syndrome in Schizophrenia
Not Applicable
Completed
Conditions
Metabolic Syndrome
Female
Schizophrenia
Interventions
Drug: berberine
Subscribe
First Posted Date
2017-08-16
Last Posted Date
2018-04-25
Lead Sponsor
Tianjin Anding Hospital
Target Recruit Count
36
Registration Number
NCT03251716
Locations
🇨🇳
Tianjin Anding Hospital, Tianjin, Tianjin, China
Subscribe
N-Acetyl Cysteine Supplementation in Therapy Refractory Major Depressive Disorders
Not Applicable
Conditions
Major Depressive Disorders
Interventions
Drug: placebo comparator of N-acetylcysteine
Drug: N-acetylcysteine
Subscribe
First Posted Date
2016-11-23
Last Posted Date
2022-09-22
Lead Sponsor
Tianjin Anding Hospital
Target Recruit Count
200
Registration Number
NCT02972398
Locations
🇨🇳
Tianjin Anding Hospital, Tianjin, Tianjin, China
Subscribe
Berberine Effect on Cytokine, CRP, Metabolic Disturbance as an Adjunctive Therapy in Schizophrenia Patients
Not Applicable
Completed
Conditions
Schizophrenia
Interventions
Drug: Placebo
Drug: Berberine
Subscribe
First Posted Date
2016-10-18
Last Posted Date
2018-05-17
Lead Sponsor
Tianjin Anding Hospital
Target Recruit Count
100
Registration Number
NCT02936414
Locations
🇨🇳
Tianjin Anding Hospital, Tianjin, Tianjin, China
Subscribe
Prev
1
2
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy